Edgewise Therapeutics Insider Moves: CMO Buys at Discount, Sells at Premium – What It Means for Investors
Edgewise Therapeutics insider trades reveal a strategic mix of high‑price sales and deep‑discount purchases, suggesting confidence in long‑term biotech value amid market volatility.
5 minutes to read